XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE-BASED COMPENSATION
9 Months Ended
Sep. 28, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
Stock Options

For the thirteen week periods ended September 28, 2025 and September 29, 2024, the Company recognized $0.4 million and $0.2 million, respectively, of compensation expense from continuing operations related to stock options. For the thirty-nine week periods ended September 28, 2025 and September 29, 2024, the Company recognized $0.4 million and $0.5 million, respectively, of compensation expense from continuing operations related to stock options. Unamortized share-based compensation expense from continuing operations as of September 28, 2025 amounted to $0.3 million which is expected to be recognized over the next 2.5 years. As of September 28, 2025, a total of 1.3 million shares remain available for issuance under 2013 Plan.

 A summary of stock option activity is presented as follows:
 Number of
Shares
Weighted Average Exercise Price Per ShareWeighted Average Remaining Contractual LifeTotal Intrinsic Value of Awards
(in thousands)
Options outstanding at December 29, 2024901,612 $15.41 5.3$— 
Granted81,686 5.46 
Forfeited / Canceled(161,495)12.22 
Options outstanding at September 28, 2025821,803 $15.05 4.3$
Options exercisable at December 29, 2024717,076 $16.59 4.6$— 
Options exercisable at September 28, 2025752,686 $15.67 3.9$— 
 Number of
Shares
Weighted Average Grant Date Fair Value
Nonvested outstanding at December 29, 2024184,536 $7.94 
Nonvested outstanding at September 28, 202569,117 $4.02 

Restricted Stock

For the thirteen week periods ended September 28, 2025 and September 29, 2024, the Company recognized $0.1 million of compensation expense related to restricted stock awards. For the thirty-nine week periods ended September 28, 2025 and September 29, 2024, the Company recognized $0.4 million and $0.3 million, respectively, of compensation expense related to restricted stock awards. Unamortized share-based compensation expense as of September 28, 2025 amounted to $0.6 million which is expected to be recognized over the next 2.0 years.
A summary of restricted stock activity is presented as follows:
 Number of
Shares
Weighted Average Exercise Price Per Share
Restricted outstanding at December 29, 2024
74,820 $10.02 
Issued151,752 $4.93 
Vested(111,064)$6.62 
Restricted outstanding at September 28, 2025
115,508 
Nonvested outstanding at December 29, 2024
74,820 $10.02 
Nonvested outstanding at September 28, 2025
115,508 $6.60